Advanced search

Dr. Kenneth F. Buechler is a Chairman at Quidel Corp., a Member at American Association for Clinical Chemistry, a Member at American Chemical Society, a Member at International Federation of Clinical Chemistry & Lab Medicine and a Member at The Biochemical Society. He is on the Board of Directors at Sotera Wireless, Inc. and TriVirum, Inc. Dr. Buechler was previously employed as a Chairman by Sequenom, Inc., a President & Chief Scientific Officer by BioSite, Inc., a President, Director & Chief Scientific Officer by New Biosite, Inc., and a Senior Scientist by Hybritech, Inc. He also served on the board at Adnavance Technologies, Inc., Astute Medical, Inc. and Edico Genome Corp. He received his undergraduate degree from Indiana University and a doctorate degree from Indiana University.

William J.
Buechler is the founder of Buechler Capital Asset Management LLC, which was founded in 2006.
He held the title of President from 2011 to 2012.
Mr. Buechler received an undergraduate degree from San Diego State University in 1976.

Ying J.
Buechler is currently the Chief Technology Officer at Ambrx, Inc. Prior to this role, Buechler held positions at aTyr Pharma, Inc. as the Director-Protein Services, at Egen, Inc. as the Vice President-Development, at Canji, Inc. as a Scientist, and at Prizm Pharmaceuticals, Inc. as a Principal.
Buechler completed their undergraduate degree at Peking University and their doctorate degree at the University of California San Diego.